BioCardia
BCDA
23 hedge funds and large institutions have $5.78M invested in BioCardia in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
5% more funds holding
Funds holding: 22 → 23 (+1)
0.04% more ownership
Funds ownership: 1.13% → 1.18% (+0.04%)
22% less call options, than puts
Call options by funds: $149K | Put options by funds: $191K
36% less capital invested
Capital invested by funds: $9.01M → $5.78M (-$3.23M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$138K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$79.9K |
| 3 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$63.1K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$53.8K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$51.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$137K |
| 2 |
Millennium Management
New York
|
-$31K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$11.7K |
| 4 |
US Bancorp
Minneapolis,
Minnesota
|
-$11K |
| 5 |
Morgan Stanley
New York
|
-$954 |
BCDA Hedge Fund Activity: Q4 2021 in Review
23 of the 6,399 institutional investors tracked by Wall St. Rank reported a position in BioCardia (BCDA) for Q4 2021, worth a combined $5.78M — down 36% from $9.01M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BCDA positions and 3 closed out — a net gain of 1 holder — while 6 added to existing stakes and 2 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $138K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $137K sold.
- 23 institutional investors held BioCardia (BCDA) as of Q4 2021, up from 22 in Q3 2021.
- Funds reported $5.78M of BioCardia stock for Q4 2021, down 36% quarter-over-quarter.
- 4 funds opened new BioCardia positions in Q4 2021 and 3 closed out, a net change of +1 holder.
- The largest BioCardia buyer in Q4 2021 was Virtu Financial, an estimated $138K added.
- The largest BioCardia seller in Q4 2021 was Renaissance Technologies, an estimated $137K sold.
Based on aggregated 13F filings for Q4 2021.